Dr. Dasari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2008 - 2011
UPMC Medical EducationResidency, Internal Medicine, 2005 - 2008
Gandhi Medical CollegeClass of 2002
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2022 - 2026
GA State Medical License 2022 - 2026
TN State Medical License 2022 - 2026
TX State Medical License 2011 - 2026
LA State Medical License 2022 - 2025
MS State Medical License 2022 - 2025- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors Start of enrollment: 2019 Jul 30
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 9 citationsFuture direction of total neoadjuvant therapy for locally advanced rectal cancer.Yoshinori Kagawa, J Joshua Smith, Emmanouil Fokas, Jun Watanabe, Andrea Cercek
Nature Reviews. Gastroenterology & Hepatology. 2024-06-01 - 352 citationsDisparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals from 2008 to 2018Jonathan M. Loree, Seerat Anand, Arvind Dasari, Joseph M. Unger, Anirudh Gothwal
JAMA Oncology. 2019-10-01 - 168 citationsA phase I, dose-finding study in patients with advanced solid malignancies of the oral γ-secretase inhibitor PF-03084014Wells A. Messersmith, Geoffrey I. Shapiro, James M. Cleary, Antonio Jimeno, Arvind Dasari
Clinical Cancer Research. 2015-01-01
Press Mentions
FDA Approves New Blood Test to Detect Colon CancerJuly 29th, 2024- New Blood Test for Colorectal Cancer Approved by FDAJuly 29th, 2024
- FDA Approves Blood Test Method for Colon Cancer ScreeningJuly 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
